Abstract: This application discloses a calibration method, a calibration system, and a calibration board. The calibration board includes checkerboard cells arranged on a surface of the calibration board, where at least one dot is arranged in each of the checkerboard cells, the dots of the calibration board include at least a first feature dot and a second feature dot, the first feature dot and the second feature dot are arranged in the checkerboard cells according to a random rule or a specific rule, and a diameter of the first feature dot is greater than a diameter of the second feature dot. The calibration board in this application improves the stability and accuracy of calibration board detection by utilizing characteristics such as a high detection accuracy and a strong anti-blur capability of a dot mark, combining with corner points of checkerboard cells.

Abstract: A composition, formulation, preparation method and use for a glutathione precursor. The composition comprises, in parts by weight: a selenium-containing compound; a glutathione precursor; a zinc-containing compound. A powder obtained by mixing the present composition has good mixing uniformity and good fluidity, and facilitates filling in a filling capsule; and a capsule containing the composition has the effects of liver protection, oxidation resistance, and immunity enhancement.

Abstract: Disclosed is application of acetylacetone in inhibiting the growth of cyanobacteria, that is, acetylacetone is added in water disturbed with cyanobacteria, and the dosage of acetylacetone is not less than 7 mg/L to inhibit the growth of cyanobacteria. Acetylacetone inhibits the growth of cyanobacteria by inhibiting photosynthesis, has a better algicidal effect than common algaecides, is harmless to common bacteria such as Escherichia coli, Salmonella, Bacillus subtilis, and Staphylococcus aureus, and is environmentally friendly and easy to popularize and apply.

Abstract: This application discloses a calibration method, a calibration system, and a calibration board. The calibration board includes checkerboard cells arranged on a surface of the calibration board, where at least one dot is arranged in each of the checkerboard cells, the dots of the calibration board include at least a first feature dot and a second feature dot, the first feature dot and the second feature dot are arranged in the checkerboard cells according to a random rule or a specific rule, and a diameter of the first feature dot is greater than a diameter of the second feature dot. The calibration board in this application improves the stability and accuracy of calibration board detection by utilizing characteristics such as a high detection accuracy and a strong anti-blur capability of a dot mark, combining with corner points of checkerboard cells.

Abstract: Disclosed is application of acetylacetone in inhibiting the growth of cyanobacteria, that is, acetylacetone is added in water disturbed with cyanobacteria, and the dosage of acetylacetone is not less than 7 mg/L to inhibit the growth of cyanobacteria. Acetylacetone inhibits the growth of cyanobacteria by inhibiting photosynthesis, has a better algicidal effect than common algaecides, is harmless to common bacteria such as Escherichia coli, Salmonella, Bacillus subtilis, and Staphylococcus aureus, and is environmentally friendly and easy to popularize and apply.

Abstract: Querying a data set formed from a version of primary data and secondary data is facilitated. First and second versions of primary data are stored in a primary data version store. Secondary data is received. The secondary data is stored in a secondary data store. A query language statement is received. The query language statement is executed by selecting query results from a data set that includes the secondary data and elements of the first version of primary data not inconsistent with the secondary data.

Abstract: The present invention provides a TiO2-based coagulant and use thereof. The TiO2-based coagulant is obtained by the following steps: uniformly mixing acetylacetone and ethanol and dropwise adding titanium tetrachloride to obtain a solution A; mixing deionized water and ethanol to obtain a solution B; dropwise adding solution B to solution A; stirring to obtain a sol, and then aging the sol to constant weight to obtain the TiO2-based coagulant. The TiO2-based coagulant can be used for treating waste water and algae-laden water. The TiO2-based coagulant exhibits good coagulation effects and high stability, solves the problem of too low effluent pH caused by strong inorganic titanate acidity and is favorable to the subsequent treatment of waste water.

Abstract: Technologies are described for facilitating querying a data set formed from a version of primary data and secondary data. First and second versions of primary data are stored in a primary data version store. Secondary data is received. The secondary data is stored in a secondary data store. A query language statement is received. The query language statement is executed by selecting query results from a data set that includes the secondary data and elements of the first version of primary data not inconsistent with the secondary data.

Abstract: This invention relates to the field of molecular physiology. Specifically, this invention relates to the treatment of vasculoproliferative conditions, especially those of the eye and in the treatment of tumours that exhibit vascular proliferation. Levels of leucine-rich alpha-2-glycoprotein (Lrg1) have been demonstrated to be increased in patients suffering from such conditions and animal models of such conditions. Antagonists of Lrg1 can be used to treat vasculoproliferative conditions.

Abstract: The present invention provides a TiO2-based coagulant and use thereof. The TiO2-based coagulant is obtained by the following steps: uniformly mixing acetylacetone and ethanol and dropwise adding titanium tetrachloride to obtain a solution A; mixing deionized water and ethanol to obtain a solution B; dropwise adding solution B to solution A; stirring to obtain a sol, and then aging the sol to constant weight to obtain the TiO2-based coagulant. The TiO2-based coagulant can be used for treating waste water and algae-laden water. The TiO2-based coagulant exhibits good coagulation effects and high stability, solves the problem of too low effluent pH caused by strong inorganic titanate acidity and is favorable to the subsequent treatment of waste water.

Abstract: This invention relates to the field of molecular physiology. Specifically, this invention relates to the prevention and/or treatment of cancer. Leucine-rich alpha-2-glycoprotein (Lrg1) has been demonstrated to be expressed in a range of cancer cells. Antagonists of Lrg1 can be used to prevent and/or treat cancer by an effect on neoplastic cells.

Abstract: Disclosed are a method and a device for detecting traffic signs in an input image camera. The method comprises a color space converting step of converting the input image into a HSV color space image; a filtering step of filtering, based on a predetermined pass range of a standard color of each of the traffic signs, the HSV color space image to obtain a filtered image, and then generating one or more connected domains based on one or more regions in the filtered image; a removing step of removing, based on a standard rule of the corresponding traffic sign, at least one of the generated connected domains, not being the corresponding traffic sign, and letting others of the generated connected domains be candidate traffic sign domains; and a recognition step of recognizing, based on a feature of each of the candidate traffic sign domains, the corresponding traffic sign.

Abstract: This invention relates to the field of molecular physiology. Specifically, this invention relates to the treatment of vasculoproliferative conditions, especially those of the eye and in the treatment of tumours that exhibit vascular proliferation. Levels of leucine-rich alpha-2-glycoprotein (Lrg1) have been demonstrated to be increased in patients suffering from such conditions and animal models of such conditions. Antagonists of Lrg1 can be used to treat vasculoproliferative conditions.

Abstract: Disclosed are a scene video switch system and a scene video switch method. The system comprises an input unit configured to input an image currently captured by a video capture unit to serve as a current image; a detection unit configured to detect all of interesting elements and latent elements in the current image so as to determine a maximum possible existing area of the interesting elements; a state switch unit configured to carry out, by using a predetermined finite state machine, switching between scene states of the maximum possible existing area according to predetermined different scene states and switching conditions; and a display unit configured to extract, based on a current scene state switched by the state switch unit, an area of concern coinciding with the current scene state from the maximum possible existing area to serve as a scene video for display.

Abstract: A method for detecting a front vehicle comprises: a moving light detecting step of detecting a front moving light area of an own vehicle in at least one image of a front scene of the own vehicle obtained at a time; a vehicle candidate generating step of extracting a light area pair from the detected front moving light area so that a front vehicle candidate is generated; and a vehicle candidate verifying step of verifying that the front vehicle candidate is the front vehicle in cases where the front vehicle candidate meets predetermined characteristics of a vehicle light.

Abstract: This invention relates to the field of molecular physiology. Specifically, this invention relates to treatment of vasculoproliferative conditions, especially those of the eye and in the treatment of tumours that exhibit vascular proliferation. Levels of leucine-rich alpha-2-glycoprotein (Lrg1) have been demonstrated to be increased in patients suffering from such conditions and animal models of such conditions. Antagonists of Lrg1 can be used to treat vasculoproliferative conditions.

Abstract: Disclosed is a processing method used in a video conference system having a local terminal device and at least one remote terminal device, comprising a feature detection step of carrying out a feature detection in the local terminal device and the remote terminal device, respectively; a conference mode setting step of setting a conference mode for the local terminal device and the remote terminal device, respectively; and a video encoding step of dividing a video frame in the local terminal device and the remote terminal device, and then pre-processing the divided areas so as to encode the pre-processed areas, respectively.

Abstract: A method for detecting a front vehicle comprises: a moving light detecting step of detecting a front moving light area of an own vehicle in at least one image of a front scene of the own vehicle obtained at a time; a vehicle candidate generating step of extracting a light area pair from the detected front moving light area so that a front vehicle candidate is generated; and a vehicle candidate verifying step of verifying that the front vehicle candidate is the front vehicle in cases where the front vehicle candidate meets predetermined characteristics of a vehicle light.

Abstract: Disclosed are a method and a device for detecting traffic signs in an input image camera. The method comprises a color space converting step of converting the input image into a HSV color space image; a filtering step of filtering, based on a predetermined pass range of a standard color of each of the traffic signs, the HSV color space image to obtain a filtered image, and then generating one or more connected domains based on one or more regions in the filtered image; a removing step of removing, based on a standard rule of the corresponding traffic sign, at least one of the generated connected domains, not being the corresponding traffic sign, and letting others of the generated connected domains be candidate traffic sign domains; and a recognition step of recognizing, based on a feature of each of the candidate traffic sign domains, the corresponding traffic sign.

Abstract: This invention relates to the field of molecular physiology. Specifically, this invention relates to the prevention and/or treatment of vasculoproliferative conditions, especially those of the eye and in the treatment of tumours that exhibit vascular proliferation. Levels of leucine-rich alpha-2-glycoprotein (Lrg1) have been demonstrated to be increased in patients suffering from such conditions and animal models of such conditions. Antagonists of Lrg1 can be used to prevent and/or treat vasculoproliferative conditions.